BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16614866)

  • 1. [EURAP: the European Registry of Antiepileptic Drugs and Pregnancy].
    Kretz R; Coban I; Gaus V; Schmitz B
    Nervenarzt; 2006 Jun; 77(6):722, 724-8. PubMed ID: 16614866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
    Tomson T; Perucca E; Battino D
    Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malformations in the offspring of pregnant women with epilepsy. Presentation of an international registry of antiepileptic drugs and pregnancy (EURAP)].
    Battino D; Mamoli D; Messina S; Perucca E; Tomson T
    Rev Neurol; 2002 Mar 1-15; 34(5):476-80. PubMed ID: 12040519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries.
    Tomson T; Battino D; French J; Harden C; Holmes L; Morrow J; Robert-Gnansia E; Scheuerle A; Vajda F; Wide K; Gordon J
    Epilepsy Behav; 2007 Nov; 11(3):277-82. PubMed ID: 17996635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine in pregnancy: clinical experience in Argentina.
    Meischenguiser R; D'Giano CH; Ferraro SM
    Epilepsy Behav; 2004 Apr; 5(2):163-7. PubMed ID: 15123016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A North American Registry for Epilepsy and Pregnancy, a unique public/private partnership of health surveillance.
    Epilepsia; 1998 Jul; 39(7):793-8. PubMed ID: 9670909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry.
    Vajda FJ; Hitchcock A; Graham J; Solinas C; O'Brien TJ; Lander CM; Eadie MJ
    Eur J Neurol; 2006 Jun; 13(6):645-54. PubMed ID: 16796590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Anti-Epileptic Drug modifications after first trimester of pregnancy influence fetal malformation or cognitive outcome?
    Asranna A; Jose M; Philip RM; Sarma PS; Thomas SV
    Epilepsy Res; 2018 Oct; 146():121-125. PubMed ID: 30098567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
    Thomas SV; Jose M; Divakaran S; Sankara Sarma P
    Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.
    Bhakta J; Bainbridge J; Borgelt L
    Epilepsy Behav; 2015 Nov; 52(Pt A):212-7. PubMed ID: 26460786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth defects after prenatal exposure to antiepileptic drugs.
    Perucca E
    Lancet Neurol; 2005 Nov; 4(11):781-6. PubMed ID: 16239185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications.
    Jazayeri D; Graham J; Hitchcock A; O'Brien TJ; Vajda FJE
    Seizure; 2018 Mar; 56():111-114. PubMed ID: 29471258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry.
    Eurap Study Group
    Epilepsia; 2009 Oct; 50(10):2305-9. PubMed ID: 19453723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing?
    Palmieri C; Canger R
    CNS Drugs; 2002; 16(11):755-64. PubMed ID: 12383031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy and teratogenicity of antiepileptic drugs.
    Eroğlu E; Gökçil Z; Bek S; Ulaş UH; Odabaşi Z
    Acta Neurol Belg; 2008 Jun; 108(2):53-7. PubMed ID: 18795597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EURAP: an international registry of antiepileptic drugs and pregnancy.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Vajda F;
    Epilepsia; 2004 Nov; 45(11):1463-4. PubMed ID: 15509250
    [No Abstract]   [Full Text] [Related]  

  • 19. Levetiracetam Pregnancy Registry: Final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations.
    Scheuerle AE; Holmes LB; Albano JD; Badalamenti V; Battino D; Covington D; Harden C; Miller D; Montouris GD; Pantaleoni C; Thorp J; Tofighy A; Tomson T; Golembesky AK
    Birth Defects Res; 2019 Aug; 111(13):872-887. PubMed ID: 31124321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic drugs, foetal malformations and spontaneous abortions.
    Vajda FJ; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
    Acta Neurol Scand; 2017 Mar; 135(3):360-365. PubMed ID: 27573510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.